What You Should Know:
- AnswersNow, the leader in virtual Applied Behavioral Analysis (ABA) therapy, today announced that it has raised $40 million in Series B funding led by HealthQuest Capital, with participation from existing investors Left Lane Capital, Owl Ventures, and others.
- AnswersNow delivers clinically proven outcomes in one-sixth the hours of traditional therapy, creating substantial cost savings for payors while delivering superior results for families.
AnswersNow Scales
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
How Crossroads Health Ventures’ $21M Fund Accelerates Indiana Life Sciences
What You Should Know
The News: Crossroads Health Ventures (CHV) has launched a new early-stage venture fund with over $21M in capital to support Indiana-based life sciences startups.The Backers: The fund represents a rare collaboration between the state (IEDC), academia (Indiana University), and three global industry leaders: Eli Lilly (human health), Elanco (animal health), and Corteva (plant health).The Strategy: CHV aims to bridge the early-stage funding gap for companies operating
Read More
Vista AI Secures $29.5M to Scale Automated Scanning Across Brain, Spine, and Prostate
What You Should Know
Vista AI, a provider of automated MRI scanning software for hospitals and imaging centers secures $29.5M in Series B financing, backed by a powerhouse group of new investors including Cedars-Sinai, Intermountain Health, and Tampa General Hospital.
- The funding will accelerate the expansion of the company's FDA-cleared automated MRI scanning platform into new anatomies—including brain, spine, and prostate—while scaling remote scanning services to address the national
Read More
MARS Bioimaging Secures $15M to Scale World’s First Portable Spectral CT Scanners
What You Should Know
- MARS Bioimaging, a New Zealand–headquartered pioneer in medical imaging, secures $15M in Series A funding round. Led by Pacific Channel.
- The capital will be used to scale the commercial adoption of the world’s first portable spectral photon-counting CT scanners—technology that delivers high-resolution, 3D color images to the point of care.
The Spectral Shift: 3D Color vs. Black-and-White
Traditional CT scans are typically low-resolution, black-and-white
Read More
Converge Bio Lands $25M to Replace Trial-and-Error Drug Discovery
What You Should Know
- Converge Bio has announced a $25M Series A funding round led by Bessemer Venture Partners, bringing its total raised to $30M.
- Moving beyond the "AI promise" gap, the company provides end-to-end AI systems that plug directly into existing drug development workflows, already serving over a dozen pharmaceutical and biotech customers to optimize target discovery and protein manufacturing.
The Systemic Pivot: Bridging the Gap Between Promise and Reality
While
Read More
Xella Health Raises $3.7M to Pioneer AI-Powered Menstrual Fluid Diagnostics
What You Should Know
- Xella Health has emerged from stealth with $3.7M in pre-seed financing to build the infrastructure for "decoding" female biology.
- Led by Precursor Ventures, the company is pioneering a first-of-its-kind diagnostic platform that combines menstrual fluid analysis with peripheral blood and AI-powered multi-omics to identify the root causes of chronic conditions like endometriosis, PCOS, and perimenopause.
The Biological Signal: Tapping Into Menstrual
Read More
Mitch Rales Leads $43M Round to Scale VieCure’s AI Oncology Platform
What You Should Know:
- VieCure has raised $43M led by Mitch Rales (co-founder of Danaher) and Northpond Ventures. The funding will scale VieCure's Halo Intelligence™ platform, an AI-powered clinical decision support system that has already increased tumor sequencing rates by 8x for 30,000 patients.
- Through a partnership with Rales' firm New Bearing, VieCure will implement a world-class business system to modernize community oncology clinics, which treat 80% of U.S. cancer
Read More
Allos AI Raises $5M to Reformulate Complex Drugs with Glass-Box Causal AI
What You Should Know
- Allos AI has emerged from stealth with $5 million in seed financing led by Oxford Science Enterprises (OSE) to commercialize the industry’s first “glass-box” Causal AI platform.
- Unlike traditional AI that focuses on discovering new molecules, Allos targets the "formulation gap"—applying causal modeling to existing complex generics and next-generation medicines to improve their tolerability, bioavailability, and long-term patient outcomes.
The Problem: The
Read More
Pomelo Care Secures $92M to Scale Virtual Maternity Model Across Women’s Health
What You Should Know
- Pomelo Care has closed a $92 million Series C funding round, propelling the company to a $1.7B valuation.
- After proving its virtual model can reduce preterm births by 37% and emergency room visits by 46%, Pomelo is moving beyond its maternity roots to launch comprehensive pediatric and midlife care programs, now covering more than 25 million lives nationwide.
The Accountability Pivot: Evidence Over Hype
In a 2026 market where "Agentic AI" and "Digital
Read More
The Automated OR: Apella Secures $80M to Scale Ambient Video Intelligence Across the Surgical Suite
What You Should Know
- Apella has announced an $80M Series B round to scale its ambient AI platform designed for the most complex environment in the hospital: the operating room (OR). The round was led by HighlandX, with returning investors Vensana Capital, Casdin Capital, PFM Health Sciences, Upside Partnership, and Operator Partners, and includes new investors K2 HealthVentures, OpAmp Capital, and Houston Methodist.
- By using computer vision to autonomously identify 14 surgical
Read More
